IP Library Patent Application 11470724
Patent Application
App. No. 11/470,724

ENHANCEMENT OF LENS REGENERATION USING MATERIALS COMPRISING POLYMERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/470,724
Abstract

The present invention addresses the treatment of ocular conditions by the enhancement of lens regeneration. Enhancement of lens regeneration is accomplished by the administration of a viscoelastic material in association with a composition comprising a polymer having functional acryl groups useful in the preparation of intraocular lenses (IOLs).

Claims (36)

1 . A method of enhancing regeneration of lens cells in a mammal after endocapsular extraction comprising filling a lens capsule bag of said mammal with an injectable lens material comprising a polymer wherein said injectable lens material has a viscosity for being injected through standard cannula and said polymer has functional groups at terminal ends of said polymer.

2 . A method according to claim 1 wherein said polymer is a polysiloxane polymer.

3 . A method according to claim 1 wherein said endocapsular extraction occurs through a capsulorrhexis that is 3 millimeters or less.

4 . A method according to claim 1 wherein said method further comprises inserting a foldable intraocular lens into said capsule bag of said mammal.

5 . A method according to claim 1 wherein a contact lens or similar polymeric material in the form of a permeable or semi-permeable disc shaped lens is positioned between the anterior capsule and said injectable lens material or positioned between said injectable lens material and the posterior capsule.

6 . A method according to claim 1 wherein said method further comprises administering a viscoelastic material to said capsule bag of said mammal.

7 . A method according to claim 6 wherein said viscoelastic material is selected from the group consisting of hyaluronic acid, cellulosic materials, collagen, and combinations thereof.

8 . A method according to claim 7 , wherein said viscoelastic material is hyaluronic acid and said hyaluronic acid is a crosslinked hyaluronic acid.

9 . A method according to claim 6 , wherein said method further comprises the administration of hyaluronidase.

10 . A method according to claim 1 wherein said injectable lens material further comprises a photoinitiator and is capable of being photopolymerized into a solid intraocular lens.

11 . A method according to claim 2 , wherein said polysiloxane polymer has a backbone of the general formula:

wherein R 1 and R 2 are independently C 1 -C 6 alkyl; R 3 is phenyl; R 4 is phenyl or C 1 -C 6 alkyl; R 5 is CF 3 (CH 2 ) x , wherein x is 1-5; R 6 is C 1 -C 6 alkyl or fluoroalkyl; l is in the molar fraction range of 0 to 0.95; m is in the molar fraction range of from greater than 0 to 0.7; and n is in the molar fraction range of from greater than 0 to 0.65.

12 . A method according to claim 1 , further comprising inserting at least one collagen patch in said capsule bag of said mammal.

13 . A kit comprising (i) a polysiloxane polymer; and (ii) instructional materials wherein said instructional materials direct the use of said polysiloxane polymer in enhancing regeneration of lens cells.

14 . A kit according to claim 13 wherein said polysiloxane polymer is photocurable.

15 . A kit according to claim 13 wherein said kit further comprises a viscoelastic material and said instructional materials direct the use of said polysiloxane polymer and said viscoelastic material in enhancing regeneration of lens cells.

16 . A kit according to claim 15 wherein said viscoelastic material is selected from the group consisting of hyaluronic acid, cellulosic materials, collagen, and combinations thereof.

17 . A kit according to claim 13 wherein said kit further comprises hyaluronidase and said instructional materials direct the use of said polysiloxane polymer and said hyaluronidase in enhancing regeneration of lens cells.

18 . A kit according to claim 13 wherein said kit further comprises a collagen patch and said instructional materials direct the use of said polysiloxane polymer and said collagen patch in enhancing regeneration of lens cells.

19 . A kit according to claim 13 wherein said kit further comprises hyaluronic acid and a collagen patch and said instructional materials direct the use of said polysiloxane polymer, said hyaluronic acid and said collagen patch in enhancing regeneration of lens cells.

20 . A kit according to claim 13 wherein said kit further comprises an intraocular lens and said instructional materials direct the use of said polysiloxane polymer and said intraocular lens in enhancing regeneration of lens cells.

21 . A kit according to claim 13 wherein said kit further comprises a contact lens or similar polymeric material in the form of a permeable or semi-permeable disc shaped lens and said instructional materials direct the use of said polysiloxane polymer and said contact lens or similar polymeric material in the form of a permeable or semi-permeable disc shaped lens in enhancing regeneration of lens cells.

22 . A kit according to claim 13 wherein said instructional materials direct that said endocapsular extraction occurs through a capsulorrhexis that is 3 millimeters or less in length.

23 . A kit according to claim 13 wherein said polysiloxane polymer has a backbone of the general formula:

wherein R 1 and R 2 are independently C 1 -Calkyl; R 3 is phenyl; R 4 is phenyl or C 1 -C 6 alkyl; R 5 is CF 3 (CH 2 ) x wherein x is 1-5; R 6 is C 1 -C 6 alkyl or fluoroalkyl; l is in the molar fraction range of 0 to 0.95; m is in the molar fraction range of from greater than 0 to 0.7; and n is in the molar fraction range of from greater than 0 to 0.65.

24 . A method of promoting accommodation in the lens of an eye after endocapsular extraction comprising:

coating the lens capsule bag with a viscoelastic material; and

filling said lens capsule bag with an injectable lens material comprising a polymer wherein said injectable lens material has a viscosity for being injected through standard cannula and said polymer has functional groups at terminal ends of said polymer.

25 . A method according to claim 24 wherein said polymer is a polysiloxane polymer.

26 . A method according to claim 24 wherein said viscoelastic material is selected from the group consisting of hyaluronic acid, cellulosic materials, collagen, and combinations thereof.

27 . A method of according to claim 24 wherein said eye is a presbyopic or cataractous eye.

28 . A method according to claim 24 wherein said endocapsular extraction occurs through a capsulorrhexis that is 3 millimeters or less.

29 . A method according to claim 24 wherein said injectable lens material further comprises a photoinitiator and is capable of being photopolymerized into a solid intraocular lens.

30 . A method according to claim 25 , wherein said polysiloxane polymer has a backbone of the general formula:

wherein R 1 and R 2 are independently C 1 -C 6 alkyl; R 3 is phenyl; R 4 is phenyl or C 1 -C 6 alkyl; R 5 is CF 3 (CH 2 ) x wherein x is 1-5; R 6 is C 1 -C 6 alkyl or fluoroalkyl; l is in the molar fraction range of 0 to 0.95; m is in the molar fraction range of from greater than 0 to 0.7; and n is in the molar fraction range of from greater than 0 to 0.65.

31 . A method according to claim 24 , further comprising inserting at least one collagen patch in said capsule bag of said mammal.

Assignments (4)
MERGER Recorded Jul 29, 2009
From: ADVANCED MEDICAL OPTICS, INC.
To: ABBOTT MEDICAL OPTICS INC.
Reel/Frame 023234/0277 →
RELEASE OF SECURITY INTEREST Recorded Feb 27, 2009
From: BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 022320/0427 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 29, 2007
From: ADVANCED MEDICAL OPTICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 019501/0069 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2007
From: GWON, ARLENE E.
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 018910/0200 →